A Uk Based Cost-Effectiveness Analysis Of Glycopyrronium Bromide A New Anti-Muscarinic Agent For The Maintenance Treatment Of Patients With COPD

被引：0
|
作者：
Malcolm, W. A. [1 ]
Keyzor, I. [1 ]
Radwan, A. [1 ]
Price, D. B. [2 ]
Asukai, Y. [3 ]
Ananthapavan, J. [3 ]
机构：
[1] Novartis Pharmaceut, Frimley, England
[2] Univ Aberdeen, Aberdeen, Scotland
[3] IMS Hlth, London, England
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2013年 / 187卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A2156
引用
收藏
页数：1
相关论文
共 50 条
  • [21] China county based COPD screening and cost-effectiveness analysis
    Du, Minghua
    Hu, Hao
    Zhang, Lei
    Liu, Wenpeng
    Chu, Tianbao
    Wu, Guoxia
    Wang, Xiaoling
    Li, Ling
    Wang, Jing
    Zheng, Lingling
    Bai, Shuchen
    ANNALS OF PALLIATIVE MEDICINE, 2021, 10 (04) : 4652 - 4660
  • [22] A Uk Based Cost-Utility Analysis Of Indacaterol Versus Formoterol For The Maintenance Treatment Of Moderate To Severe COPD Patients
    Malcolm, W. A.
    Keyzor, I.
    Radwan, A.
    Asukai, Y.
    Ananthapavan, J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
  • [23] Cost-effectiveness analysis of a large jail-based methadone maintenance treatment continuation program in New Mexico
    Horn, Brady P.
    Li, Xiaoxue
    McCrady, Barbara
    Guerin, Paul
    French, Michael T.
    JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2020, 115
  • [24] Cost-effectiveness of new treatments for overactive bladder: The example of tolterodine, a new muscarinic agent: A Markov model
    Kobelt, G
    Jonsson, L
    Mattiasson, A
    NEUROUROLOGY AND URODYNAMICS, 1998, 17 (06) : 599 - 611
  • [25] COST-EFFECTIVENESS ANALYSIS OF TIOTROPIUM IN THE TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) PATIENTS IN SPAIN
    Brosa, M.
    Diaz, S.
    Miravitlles, M.
    Gonzalez-Rojas, N.
    Nieves, D.
    VALUE IN HEALTH, 2009, 12 (07) : A302 - A302
  • [26] COST-EFFECTIVENESS OF RIVAROXABAN IN THE TREATMENT OF PATIENTS WITH CHRONIC CAD OR PAD IN THE UK
    Cowie, M. R.
    Lamy, A.
    Levy, P.
    Mealing, S.
    Millier, A.
    Mernagh, P.
    Cristeau, O.
    Briere, J. B.
    Bowrin, K.
    VALUE IN HEALTH, 2019, 22 : S550 - S550
  • [27] COST-EFFECTIVENESS ANALYSIS OF THE FIXED COMBINATION INDACATEROL/GLYCOPYRRONIUM VS. TIOTROPIUM AND SALMETEROL/FLUTICASONE IN THE MANAGEMENT OF COPD IN GREECE
    Geitona, M.
    Kousoulakou, H.
    Kalogeropoulou, M.
    Mitsiki, E.
    Panitti, E.
    Steiropoulos, P.
    VALUE IN HEALTH, 2015, 18 (07) : A500 - A500
  • [28] A COST-EFFECTIVENESS ANALYSIS OF FENFLURAMINE FOR THE TREATMENT OF SEIZURES FOR PATIENTS WITH DRAVET SYNDROME (DS) IN THE UK SETTING
    Weston, G.
    Pinsent, A.
    Adams, E.
    Linley, W.
    Hawkins, N.
    Schwenkglenks, M.
    Hamlyn-Williams, C.
    Toward, T.
    VALUE IN HEALTH, 2021, 24 : S164 - S165
  • [29] Methylnaltrexone bromide for the treatment of opioid-induced constipation in patients with advanced illness - a cost-effectiveness analysis
    Earnshaw, S. R.
    Klok, R. M.
    Iyer, S.
    McDade, C.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2010, 31 (08) : 911 - 921
  • [30] Cost-effectiveness analysis of antifungal treatment for patients on chemotherapy
    Nomura, K
    Kawasugi, K
    Morimoto, T
    EUROPEAN JOURNAL OF CANCER CARE, 2006, 15 (01) : 44 - 50
12345